Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,851 | 27 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $499.17 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $469.35 | 7 | $0 (2024) |
| Novo Nordisk Inc | $429.92 | 9 | $0 (2023) |
| Abbott Laboratories | $169.25 | 1 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $125.00 | 1 | $0 (2022) |
| Cardiovascular Systems Inc. | $80.80 | 1 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $39.21 | 2 | $0 (2023) |
| PFIZER INC. | $23.45 | 1 | $0 (2022) |
| Lilly USA, LLC | $14.84 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $585.23 | 5 | ABBVIE INC. ($225.90) |
| 2023 | $963.84 | 15 | Novo Nordisk Inc ($395.36) |
| 2022 | $221.12 | 6 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($125.00) |
| 2020 | $80.80 | 1 | Cardiovascular Systems Inc. ($80.80) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $169.25 | General |
| Category: Diabetes Care | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $104.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $96.28 | General |
| Category: NEUROSCIENCE | ||||||
| 03/20/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $86.04 | General |
| Category: Respiratory | ||||||
| 02/01/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $129.62 | General |
| Category: NEUROSCIENCE | ||||||
| 12/16/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $102.70 | General |
| 11/30/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $148.27 | General |
| Category: NEUROSCIENCE | ||||||
| 08/16/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $119.43 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/27/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/20/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $6.56 | General |
| Category: Diabetes | ||||||
| 05/18/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $113.04 | General |
| Category: Respiratory | ||||||
| 05/11/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $110.43 | General |
| 05/10/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 05/09/2023 | Novo Nordisk Inc | Rybelsus (Drug), Tresiba, Ozempic | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Diabetes | ||||||
| 04/27/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.84 | General |
| Category: Diabetes | ||||||
| 04/25/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Diabetes | ||||||
| 04/13/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.48 | General |
| Category: DIABETES | ||||||
| 03/21/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $121.81 | General |
| 03/19/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/19/2023 | Novo Nordisk Inc | Tresiba (Drug), Ozempic, Rybelsus | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: Diabetes | ||||||
| 12/13/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Diabetes | ||||||
| 11/10/2022 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Gastroenterology | ||||||
| 11/02/2022 | Novo Nordisk Inc | Tresiba (Drug), Ozempic, Rybelsus | Food and Beverage | In-kind items and services | $18.65 | General |
| Category: Diabetes | ||||||
| 11/01/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/26/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 283 | 416 | $102,834 | $35,476 |
| 2022 | 1 | 38 | 40 | $8,880 | $3,834 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 184 | 316 | $78,252 | $24,879 | 31.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 50 | 50 | $12,686 | $6,396 | 50.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 20 | 20 | $6,608 | $2,201 | 33.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 29 | 30 | $5,288 | $2,001 | 37.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 38 | 40 | $8,880 | $3,834 | 43.2% |
About Dr. Mohammad Atif, MD
Dr. Mohammad Atif, MD is a Family Medicine healthcare provider based in N Las Vegas, Nevada. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/21/2019. The National Provider Identifier (NPI) number assigned to this provider is 1801457882.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammad Atif, MD has received a total of $1,851 in payments from pharmaceutical and medical device companies, with $585.23 received in 2024. These payments were reported across 27 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($1,851).
As a Medicare-enrolled provider, Atif has provided services to 321 Medicare beneficiaries, totaling 456 services with total Medicare billing of $39,310. Data is available for 2 years (2022–2023), covering 5 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Student in an Organized Health Care Education/Training Program
- Location N Las Vegas, NV
- Active Since 06/21/2019
- Last Updated 08/30/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1801457882
Products in Payments
- QULIPTA (Drug) $499.17
- FARXIGA (Drug) $270.27
- BREZTRI (Drug) $199.08
- FREESTYLE LIBRE 3 (Device) $169.25
- RELISTOR (Drug) $125.00
- Peripheral Orbital Atherectomy System (Device) $80.80
- Rybelsus (Drug) $42.46
- JARDIANCE (Drug) $39.21
- Tresiba (Drug) $36.61
- ELIQUIS (Drug) $23.45
- Ozempic (Drug) $15.91
- MOUNJARO (Drug) $14.84
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in N Las Vegas
William Jacks, Md, MD
Family Medicine — Payments: $16,485
Dr. Binh Tran, Md, MD
Family Medicine — Payments: $13,281
Jeaniene Talley, Md, MD
Family Medicine — Payments: $3,204
Lara Wenner, Md, MD
Family Medicine — Payments: $1,991
Peter Asafo-Adjei, M.d, M.D
Family Medicine — Payments: $749.28
Dr. Zephyrene Villaluz, M.d, M.D
Family Medicine — Payments: $187.91